Literature DB >> 3435703

Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.

G J Finlay1, W R Wilson, B C Baguley.   

Abstract

The cytotoxic effects of chemotherapeutic drugs on quiescent and actively proliferating cells of a Lewis lung carcinoma (LLTC) cell line have been examined. The sensitivities of cells in plateau-phase and exponentially growing cultures were compared with those of cells recovered from large subcutaneous tumours both immediately after tumour disaggregation and after one or 4 days in culture. Flow cytometric analysis indicated that when cells freshly prepared from tumours were placed into culture, they underwent extensive recruitment into S-phase. Several drugs were less cytotoxic towards both plateau-phase cultured cells and cells freshly isolated from tumours than they were against exponentially growing cells. These included amsacrine, its 4-methyl-5-(N-methyl)carboxamide derivative CI-921, doxorubicin, and nitrogen mustard. In contrast to these drugs, chlorambucil and plasma from cyclophosphamide-treated mice did not show decreased activity against slowly proliferating cells from cultures or tumours relative to cells in an actively proliferating state. The similar sensitivities of plateau-phase cultured cells and cells taken directly from large growing tumours is direct evidence that plateau-phase cultures are a useful approximation to the state of cytokinetic resistance to chemotherapeutic drugs that prevails in solid tumours, although they may not fully reflect the cytokinetic heterogeneity present in tumours.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435703      PMCID: PMC2002410          DOI: 10.1038/bjc.1987.284

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.

Authors:  B K Bhuyan; T J Fraser; K J Day
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

2.  Sensitivity to melphalan as a function of transport activity and proliferative rate in BALB/c 3T3 fibroblasts.

Authors:  R Blosmanis; J A Wright; G J Goldenberg
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

Review 3.  Are cell kinetic data relevant for the design of tumour chemotherapy schedules?

Authors:  L M van Putten
Journal:  Cell Tissue Kinet       Date:  1974-09

4.  Nitrogen mustard sensitivity and choline transport in Walker 256 carcinosarcoma cells in vitro.

Authors:  G J Goldenberg; B K Sinha
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.

Authors:  S C Barranco; J K Novak
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

6.  Transport of nitrogen mustard on the transport-carrier for choline in L5178Y lymphoblasts.

Authors:  G J Goldenberg; C L Vanstone; I Bihler
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

Review 7.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

Review 8.  Cell kinetics and chemotherapy: a critical review.

Authors:  I Tannock
Journal:  Cancer Treat Rep       Date:  1978-08

9.  Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

10.  A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.

Authors:  V D Courtenay
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

View more
  2 in total

1.  Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.

Authors:  G J Finlay; K M Holdaway; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin.

Authors:  A Haldane; K M Holdaway; G J Finlay; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.